British Journal of Cancer - Table of Contents alert Volume 108 Issue 1

TABLE OF CONTENTS Volume 108, Issue 1 (1-244) Published online 15 January 2013 In this issue Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Web Focus on Lifestyle  Lifestyle is now known to contribute significantly to global cancer burdens. We highlight here some recent studies and meta-analyses that identify various factors associated with risk of developing cancer. Both prevention and increased risk have been variously associated with fruit and vegetable or whole grain product intake, meat consumption, and alcohol, and these, along with inadequate physical exercise and obesity are discussed in these papers.  Read the articles for FREE    Minireviews Top Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer P P Provenzano and S R Hingorani Br J Cancer 2013 108: 1-8; advance online publication, January 8, 2013; 10.1038/bjc.2012.569 Abstract | Full Text Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? L Bourke, P Kirkbride, R Hooper, A J Rosario, T J A Chico and D J Rosario Br J Cancer 2013 108: 9-13; advance online publication, November 29, 2012; 10.1038/bjc.2012.523 Abstract | Full Text Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA M Jefford, J Rowland, E Grunfeld, M Richards, J Maher and A Glaser Br J Cancer 2013 108: 14-20; advance online publication, December 20, 2012; 10.1038/bjc.2012.554 Abstract | Full Text Clinical Studies Top A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis A Santoro, M Simonelli, C Rodriguez-Lope, P Zucali, L H Camacho, A Granito, N Senzer, L Rimassa, G Abbadessa, B Schwartz, M Lamar, R E Savage and J Bruix Br J Cancer 2013 108: 21-24; advance online publication, January 3, 2013; 10.1038/bjc.2012.556 Abstract | Full Text The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case–control study using electronic records S Stapley, T J Peters, R D Neal, P W Rose, F M Walter and W Hamilton Br J Cancer 2013 108: 25-31; advance online publication, December 20, 2012; 10.1038/bjc.2012.551 Abstract | Full Text Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter? C Fotopoulou, K Savvatis, P Kosian, I E Braicu, G Papanikolaou, K Pietzner, S-C Schmidt and J Sehouli Br J Cancer 2013 108: 32-38; 10.1038/bjc.2012.544 Abstract | Full Text Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis J Lee, S Hahn, D-W Kim, J Kim, S N Kang, S Y Rha, K B Lee, J-H Kang and B-J Park Br J Cancer 2013 108: 39-48; advance online publication, November 22, 2012; 10.1038/bjc.2012.516 Abstract | Full Text Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group K Behringer, H Müller, H Görgen, H-H Flechtner, C Brillant, T V Halbsguth, I Thielen, D A Eichenauer, T Schober, H Nisters-Backes, M Fuchs, A Engert and P Borchmann on behalf of the German Hodgkin Study Group Br J Cancer 2013 108: 49-57; 10.1038/bjc.2012.550 Abstract | Full Text Translational Therapeutics Top Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours P A Zucali, M Simonelli, F De Vincenzo, E Lorenzi, M Perrino, M Bertossi, R Finotto, S Naimo, L Balzarini, C Bonifacio, I Timofeeva, G Rossoni, G Mazzola, A Lambiase, C Bordignon and A Santoro Br J Cancer 2013 108: 58-63; advance online publication, November 20, 2012; 10.1038/bjc.2012.506 Abstract | Full Text Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted? T C Hirst, H M Vesterinen, E S Sena, K J Egan, M R Macleod and I R Whittle Br J Cancer 2013 108: 64-71; 10.1038/bjc.2012.504 Abstract | Full Text Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma Y-C Shen, D-L Ou, C Hsu, K-L Lin, C-Y Chang, C-Y Lin, S-H Liu and A-L Cheng Br J Cancer 2013 108: 72-81; advance online publication, December 20, 2012; 10.1038/bjc.2012.559 Abstract | Full Text Altered TUBB3 expression contributes to the epothilone response of mitotic cells E Narvi, K Jaakkola, S Winsel, C Oetken-Lindholm, P Halonen, L Kallio and M J Kallio Br J Cancer 2013 108: 82-90; 10.1038/bjc.2012.553 Abstract | Full Text Molecular Diagnostics Top Radiation induced COX-2 expression and mutagenesis at non-targeted lung tissues of gpt delta transgenic mice Y Chai, G M Calaf, H Zhou, S A Ghandhi, C D Elliston, G Wen, T Nohmi, S A Amundson and T K Hei Br J Cancer 2013 108: 91-98; advance online publication, November 29, 2012; 10.1038/bjc.2012.498 Abstract | Full Text Identification of serum CCL15 in hepatocellular carcinoma Y Li, J Wu, W Zhang, N Zhang and H Guo Br J Cancer 2013 108: 99-106; 10.1038/bjc.2012.494 Abstract | Full Text Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer J W Pedersen, A Gentry-Maharaj, E-O Fourkala, A Dawnay, M Burnell, A Zaikin, A E Pedersen, I Jacobs, U Menon and H H Wandall Br J Cancer 2013 108: 107-114; advance online publication, November 20, 2012; 10.1038/bjc.2012.517 Abstract | Full Text KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients M Basso, A Strippoli, A Orlandi, M Martini, M A Calegari, G Schinzari, M Di Salvatore, T Cenci, A Cassano, L M Larocca and C Barone Br J Cancer 2013 108: 115-120; advance online publication, November 22, 2012; 10.1038/bjc.2012.526 Abstract | Full Text Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer Y Okugawa, K Tanaka, Y Inoue, M Kawamura, A Kawamoto, J Hiro, S Saigusa, Y Toiyama, M Ohi, K Uchida, Y Mohri and M Kusunoki Br J Cancer 2013 108: 121-130; advance online publication, November 22, 2012; 10.1038/bjc.2012.499 Abstract | Full Text Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma K Gebauer, I Peters, N Dubrowinskaja, J Hennenlotter, M Abbas, R Scherer, H Tezval, A S Merseburger, A Stenzl, M A Kuczyk and J Serth Br J Cancer 2013 108: 131-138; 10.1038/bjc.2012.537 Abstract | Full Text Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients J M Willder, S J Heng, P McCall, C E Adams, C Tannahill, G Fyffe, M Seywright, P G Horgan, H Y Leung, M A Underwood and J Edwards Br J Cancer 2013 108: 139-148; advance online publication, December 4, 2012; 10.1038/bjc.2012.480 Abstract | Full Text Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer I Ahmad, L B Singh, Z H Yang, G Kalna, J Fleming, G Fisher, C Cooper, J Cuzick, D M Berney, H Møller, P Scardino and H Y Leung Br J Cancer 2013 108: 149-154; 10.1038/bjc.2012.510 Abstract | Full Text Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer N R West, S E Kost, S D Martin, K Milne, R J deLeeuw, B H Nelson and P H Watson Br J Cancer 2013 108: 155-162; advance online publication, November 20, 2012; 10.1038/bjc.2012.524 Abstract | Full Text Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer C Palmieri, M P Caley, K Purshouse, A-V Fonseca, M Rodriguez-Teja, G Kogianni, L Woodley, J Odendaal, K Elliott, J Waxman and J Sturge Br J Cancer 2013 108: 163-169; advance online publication, December 20, 2012; 10.1038/bjc.2012.540 Abstract | Full Text PDK1 inhibition is a novel therapeutic target in multiple myeloma S Fujiwara, Y Kawano, H Yuki, Y Okuno, K Nosaka, H Mitsuya and H Hata Br J Cancer 2013 108: 170-178; advance online publication, November 29, 2012; 10.1038/bjc.2012.527 Abstract | Full Text Epidemiology Top Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer K E Henson, P McGale, C Taylor and S C Darby Br J Cancer 2013 108: 179-182; advance online publication, December 20, 2012; 10.1038/bjc.2012.575 Abstract | Full Text One-carbon metabolism factors and endometrial cancer risk J J Liu, A Hazra, E Giovannucci, S E Hankinson, B Rosner and I De Vivo Br J Cancer 2013 108: 183-187; advance online publication, January 8, 2013; 10.1038/bjc.2012.534 Abstract | Full Text Dietary patterns and survival in German postmenopausal breast cancer survivors A Vrieling, K Buck, P Seibold, J Heinz, N Obi, D Flesch-Janys and J Chang-Claude Br J Cancer 2013 108: 188-192; advance online publication, November 20, 2012; 10.1038/bjc.2012.521 Abstract | Full Text Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study O O Seminog and M J Goldacre Br J Cancer 2013 108: 193-198; advance online publication, December 20, 2012; 10.1038/bjc.2012.535 Abstract | Full Text The hormonal profile of benign breast disease E Samoli, D Trichopoulos, A Lagiou, P Zourna, C Georgila, P Minaki, A Barbouni, D Vassilarou, A Tsikkinis, C Sfikas, E Spanos and P Lagiou Br J Cancer 2013 108: 199-204; advance online publication, November 20, 2012; 10.1038/bjc.2012.493 Abstract | Full Text Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study C T DellaValle, C R Daniel, B Aschebrook-Kilfoy, A R Hollenbeck, A J Cross, R Sinha and M H Ward Br J Cancer 2013 108: 205-212; advance online publication, November 20, 2012; 10.1038/bjc.2012.522 Abstract | Full Text Sleep duration and incidence of colorectal cancer in postmenopausal women L Jiao, Z Duan, H Sangi-Haghpeykar, L Hale, D L White and H B El-Serag Br J Cancer 2013 108: 213-221; advance online publication, January 3, 2013; 10.1038/bjc.2012.561 Abstract | Full Text Metabolic syndrome and hepatocellular carcinoma risk F Turati, R Talamini, C Pelucchi, J Polesel, S Franceschi, A Crispo, F Izzo, C La Vecchia, P Boffetta and M Montella Br J Cancer 2013 108: 222-228; advance online publication, November 20, 2012; 10.1038/bjc.2012.492 Abstract | Full Text The etiologic role of human papillomavirus in penile cancers: a study in Vietnam H T T Do, C Koriyama, N A Khan, M Higashi, T Kato, N T Le, S Matsushita, T Kanekura and S Akiba Br J Cancer 2013 108: 229-233; advance online publication, January 8, 2013; 10.1038/bjc.2012.583 Abstract | Full Text Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up K E Jensen, S Schmiedel, B Norrild, K Frederiksen, T Iftner and S K Kjaer Br J Cancer 2013 108: 234-239; advance online publication, November 20, 2012; 10.1038/bjc.2012.513 Abstract | Full Text HPV16 genetic variation and the development of cervical cancer worldwide I Cornet, T Gheit, M R Iannacone, J Vignat, B S Sylla, A Del Mistro, S Franceschi, M Tommasino and G M Clifford the IARC HPV Variant Study Group Br J Cancer 2013 108: 240-244; advance online publication, November 20, 2012; 10.1038/bjc.2012.508 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.